AB
ANIP icon

Amalgamated Bank’s ANI Pharmaceuticals ANIP Stock Holding History

Amalgamated Bank’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$408K Sell
4,933
-250
-5% -$20.1K ﹤0.01% 1415
2026
Q1 		$399K Sell
5,183
-48
-0.9% -$3.75K ﹤0.01% 1391
2025
Q4 		$413K Buy
5,231
+165
+3% +$14.3K ﹤0.01% 1389
2025
Q3 		$464K Buy
5,066
+154
+3% +$12.6K ﹤0.01% 1339
2025
Q2 		$321K Buy
4,912
+106
+2% +$6.9K ﹤0.01% 1425
2025
Q1 		$322K Buy
4,806
+9
+0.2% +$538 ﹤0.01% 1406
2024
Q4 		$265K Buy
4,797
+74
+2% +$4.25K ﹤0.01% 1504
2024
Q3 		$282K Buy
4,723
+162
+4% +$9.88K ﹤0.01% 1494
2024
Q2 		$290K Sell
4,561
-203
-4% -$13.2K ﹤0.01% 1480
2024
Q1 		$329K Sell
4,764
-1,375
-22% -$83K ﹤0.01% 1454
2023
Q4 		$339K Sell
6,139
-583
-9% -$32.1K ﹤0.01% 1591
2023
Q3 		$390K Buy
6,722
+692
+11% +$39.9K ﹤0.01% 1529
2023
Q2 		$325K Buy
6,030
+867
+17% +$38.4K ﹤0.01% 1630
2023
Q1 		$205K Sell
5,163
-155
-3% -$6.54K ﹤0.01% 1793
2022
Q4 		$214K Sell
5,318
-201
-4% -$7.55K ﹤0.01% 1839
2022
Q3 		$177K Sell
5,519
-393
-7% -$13.5K ﹤0.01% 1896
2022
Q2 		$175K Buy
5,912
+415
+8% +$12K ﹤0.01% 1932
2022
Q1 		$155K Buy
5,497
+445
+9% +$16.6K ﹤0.01% 2035
2021
Q4 		$233K Buy
+5,052
New +$217K ﹤0.01% 1920

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
MMA
Mizuho Markets Americas New York $6.37B AUM 47.14% 1-Year Est. Return
PCM
Penn Capital Management Philadelphia, Pennsylvania $1.58B AUM 81.2% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Amalgamated Bank's ANIP Position: Q2 2026 in Review

Amalgamated Bank reduced its ANI Pharmaceuticals (ANIP) stake by 4.8% in Q2 2026, selling an estimated $20.1K and leaving 4,933 shares worth $408K. The position accounts for ﹤0.01% of the portfolio, ranked #1415.

Amalgamated Bank first reported a position in ANIP in Q4 2021 and has held it in 19 quarters since. The position peaked at $464K in Q3 2025. 116 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

  • Amalgamated Bank held 4,933 shares of ANI Pharmaceuticals worth $408K as of Q2 2026.
  • Amalgamated Bank sold 250 ANI Pharmaceuticals shares in Q2 2026, an estimated $20.1K.
  • ANI Pharmaceuticals made up ﹤0.01% of Amalgamated Bank's portfolio in Q2 2026, its #1415 holding.
  • Amalgamated Bank first reported a position in ANI Pharmaceuticals in Q4 2021 and has held it in 19 quarters since.
  • Amalgamated Bank's ANI Pharmaceuticals position peaked at $464K in Q3 2025.
  • 116 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on Amalgamated Bank's 13F filing for Q2 2026, filed 23 Jul 2026.